FDA Clearance Tracker · P960009-S422
Activa® Deep Brain Stimulation Therapy System, Percept PC BrainSense
Last checked: Nov 20, 2026Latest source record: Mar 25, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Mar 25, 2022
Approved
Time to decision
29 days
Received Feb 24, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P960009-S422
- Device name
- Activa® Deep Brain Stimulation Therapy System, Percept PC BrainSense
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Feb 24, 2022
- Decided
- Mar 25, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P960009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the following revisions to the protocol for the post-approval study (PAS), DBS for Epilepsy New Enrollment PAS: a) evaluate seizure worsening and changes in seizure frequency over time without formal hypothesis testing for safety; b) change the sample size for the primary effectiveness objective to approximately 72 evaluable subjects at 3 years (140 enrolled subjects to have 90 implanted subjects) from 112 evaluable subjects at 3 years (216 enrolled subjects to have 140 implanted subjects); c) change in baseline diary length from 84 days to 28 days; d) update to estimated study milestones; e) migration to a new Medtronic Clinical Investigation Plan (CIP) template; and f) general clerical edits (e.g., addition of lead Principal Investigator name and contact information, formatting, grammar/wording for consistency, improved readability, etc.).
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.